Author

Evangelia Papathoma

Observed names: E Papathoma, E. Papathoma, Evangelina Papathoma, Papathoma E, Papathoma, Evangelina, Ευαγγελία Παπαθωμά

Observed institutions: University of Copenhagen, University of Leicester, University of Patras, University of Southern Denmark, University of Zurich, Aarhus University Hospital, Copenhagen University Hospital, Rigshospitalet, Alexandra Hospital, Alexandra Hospital, Aalborg University

ORCID: 0000-0003-1460-6700

Observed ORCID: 0000-0003-1460-6700

OpenAlex ID: A5083871727

The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants

2007 · C. Costalos, A. Kapiki, et al. · Early Human Development · 148

Cesarean section delivery and development of food allergy and atopic dermatitis in early childhood

2016 · Evangelia Papathoma, Maria Triga, et al. · Pediatric Allergy and Immunology · 130

Cerebral Oximetry Monitoring in Extremely Preterm Infants

2023 · Mathias L. Hansen, Adelina Pellicer, et al. · New England Journal of Medicine · 113

Genetic Variants of Surfactant Proteins A, B, C, and D in Bronchopulmonary Dysplasia

2006 · J. Pavlovic, C. Papagaroufalis, et al. · Disease Markers · 70

PDF

Serum adiponectin concentrations in relation to maternaland perinatal characteristics in newborns

2004 · C Mantzoros, E Petridou, et al. · European Journal of Endocrinology · 50

Growth velocity during the first postnatal week of life is linked to a spurt of IGF‐I effect

2003 · A. Skalkidou, E. Petridou, et al. · Paediatric and Perinatal Epidemiology · 27

The Impact of Infant Feeding Regimen on Cow’s Milk Protein Allergy, Atopic Dermatitis and Growth in High-Risk Infants during the First 6 Months of Life: The Allergy Reduction Trial

2023 · Theodora Boutsikou, Mikaela Sekkidou, et al. · Nutrients · 24

PDF

The Risk Reduction Effect of a Nutritional Intervention With a Partially Hydrolyzed Whey-Based Formula on Cow's Milk Protein Allergy and Atopic Dermatitis in High-Risk Infants Within the First 6 Months of Life: The Allergy Reduction Trial (A.R.T.), a Multicenter Double-Blinded Randomized Controlled Study

2022 · Nicolaos Nicolaou, Rouzha Pancheva, et al. · Frontiers in Nutrition · 24

PDF

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

2021 · Marie Isabel Rasmussen, Mathias Lühr Hansen, et al. · Frontiers in Pediatrics · 23

PDF

Congenital tuberculous lymphadenitis in a preterm infant in Greece

2003 · Hatzistamatiou Z, Kaleyias J, et al. · Acta Paediatrica · 22

Normal range for blood flow velocity in cerebral arteries of newly born term infants

1990 · A.C. Fenton, D.B. Shortland, et al. · Early Human Development · 20

Modulation of birthweight through gestational age and fetal growth

1996 · E Petridou, D Trichopoulos, et al. · Child Care Health and Development · 19

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach

2021 · Markus Harboe Olsen, Mathias Lühr Hansen, et al. · BMC Medical Research Methodology · 14

PDF

Cord blood fatty acid‐binding protein‐4 levels are upregulated at both ends of the birthweight spectrum

2019 · Aimilia Eirini Papathanasiou, Despina D. Briana, et al. · Acta Paediatrica · 11

Birth Size and Neonatal Levels of Major Components of the IGF System: Implications for Later Risk of Cancer

2002 · A. Skalkidou, E. Petridou, et al. · Journal of Pediatric Endocrinology and Metabolism · 11

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

2024 · Maria Linander Vestager, Mathias Lühr Hansen, et al. · Trials · 10

PDF

Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece – A cross- sectional study

2024 · S. Papailiou, A. Soldatou, et al. · Vaccine · 6

Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-III

2024 · Marie Isabel Skov Rasmussen, Mathias Lühr Hansen, et al. · Trials · 3

PDF

Early life acute infections and risk for cow's milk protein allergy or atopic dermatitis at 6 months of age in high risk for allergy infants

2024 · Rouzha Pancheva, Zoi Illiodromiti, et al. · Frontiers in Pediatrics · 2

PDF

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants

2023 · Markus Harboe Olsen, Mathias Lühr Hansen, et al. · Trials · 2

PDF

Inadequate protection against measles and rubella among pregnant women in Greece during the last measles outbreak

2022 · S. Papailiou, A. Soldatou, et al. · Journal of Infection · 2

P01-255 - Maternal Postpartum Depression in Association with Autistic Traits in the Offspring

2010 · P. Salvanos, S.M. Sylvén, et al. · European Psychiatry · 2

Treatment guided by cerebral oximetry monitoring in extremely preterm infants: a Bayesian analysis of the SafeBoosC-III randomised clinical trial

2026 · Mathias Lühr Hansen, Markus Harboe Olsen, et al. · Trials · 1

PDF

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial

2026 · Marie Isabel Skov Rasmussen, Mathias L. Hansen, et al. · Archives of Pediatrics and Adolescent Medicine · 1

Optimising data completeness and quality in multicentre randomised clinical trials using central data monitoring: a pragmatic approach

2026 · Markus Harboe Olsen, Mathias Lühr Hansen, et al. · BMC Medical Research Methodology

Works count: 30

Citation count: 735

H-index: 13

I10-index: 16